Stonepine Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Stonepine Capital Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-651,211	Closed	-$1.55M	–	32
2019 Q2	$1.55M	Sell	651,211 -78,793	-11%	-$235K	1.07%	19
2019 Q1	$2.74M	Sell	730,004 -563,173	-44%	-$2.11M	1.57%	19
2018 Q4	$4.64M	Buy	1,293,177 +742,099	+135%	+$3.23M	4.08%	12
2018 Q3	$3.16M	Buy	+551,078	New	+$3.15M	1.85%	16
2018 Q2	–	Sell	-129,756	Closed	-$666K	–	35
2018 Q1	$666K	Buy	+129,756	New	+$781K	0.36%	25
2017 Q3	–	Sell	-2,878	Closed	-$13K	–	29
2017 Q2	$13K	Buy	+2,878	New	+$12.8K	0.01%	27

Other funds holding FOMX

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

DLD Asset Management New York $986M AUM 4.68% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return